Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dustin Wade Wooten, Ph.D.

Concepts

This page shows the publications Dustin Wooten has written about Positron-Emission Tomography.
Connection Strength

1.159
  1. Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects. J Nucl Med. 2017 Mar; 58(3):484-491.
    View in: PubMed
    Score: 0.208
  2. Reply to: Fitting of late dynamic [18F]MK6240 PET scans for in vivo tau quantification. Eur J Nucl Med Mol Imaging. 2020 12; 47(13):2947-2949.
    View in: PubMed
    Score: 0.067
  3. Preclinical Validation of a Single-Scan Rest/Stress Imaging Technique for 13N-Ammonia Positron Emission Tomography Cardiac Perfusion Studies. Circ Cardiovasc Imaging. 2020 01; 13(1):e009407.
    View in: PubMed
    Score: 0.065
  4. Assessment of Striatal Dopamine Transporter Binding in Individuals With Major Depressive Disorder: In Vivo Positron Emission Tomography and Postmortem Evidence. JAMA Psychiatry. 2019 08 01; 76(8):854-861.
    View in: PubMed
    Score: 0.063
  5. Multi-Modal Signatures of Tau Pathology, Neuronal Fiber Integrity, and Functional Connectivity in Traumatic Brain Injury. J Neurotrauma. 2019 12 01; 36(23):3233-3243.
    View in: PubMed
    Score: 0.063
  6. Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects. Eur J Nucl Med Mol Imaging. 2019 Sep; 46(10):2099-2111.
    View in: PubMed
    Score: 0.063
  7. Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts. J Nucl Med. 2018 01; 59(1):107-114.
    View in: PubMed
    Score: 0.055
  8. Rapid computation of single PET scan rest-stress myocardial blood flow parametric images by table look up. Med Phys. 2017 Sep; 44(9):4643-4651.
    View in: PubMed
    Score: 0.055
  9. Synthesis and preliminary PET imaging of 11C and 18F isotopologues of the ROS1/ALK inhibitor lorlatinib. Nat Commun. 2017 06 08; 8:15761.
    View in: PubMed
    Score: 0.055
  10. A Bayesian spatial temporal mixtures approach to kinetic parametric images in dynamic positron emission tomography. Med Phys. 2016 Mar; 43(3):1222-34.
    View in: PubMed
    Score: 0.050
  11. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors. J Nucl Med. 2014 Dec; 55(12):1973-9.
    View in: PubMed
    Score: 0.046
  12. PET imaging of acetylcholinesterase inhibitor-induced effects on a4ß2 nicotinic acetylcholine receptor binding. Synapse. 2013 Dec; 67(12):882-6.
    View in: PubMed
    Score: 0.042
  13. Measuring a4ß2* nicotinic acetylcholine receptor density in vivo with [(18)F]nifene PET in the nonhuman primate. J Cereb Blood Flow Metab. 2013 Nov; 33(11):1806-14.
    View in: PubMed
    Score: 0.042
  14. 5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate. Neuroimage. 2013 Aug 15; 77:125-32.
    View in: PubMed
    Score: 0.041
  15. PET imaging of a4ß2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate. J Nucl Med. 2012 Sep; 53(9):1471-80.
    View in: PubMed
    Score: 0.039
  16. Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate. J Cereb Blood Flow Metab. 2012 Aug; 32(8):1546-58.
    View in: PubMed
    Score: 0.038
  17. An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate. Nucl Med Biol. 2011 Oct; 38(7):925-32.
    View in: PubMed
    Score: 0.036
  18. In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate. Synapse. 2011 Jul; 65(7):592-600.
    View in: PubMed
    Score: 0.035
  19. Frontostriatal and Dopamine Markers of Individual Differences in Reinforcement Learning: A Multi-modal Investigation. Cereb Cortex. 2018 12 01; 28(12):4281-4290.
    View in: PubMed
    Score: 0.015
  20. Quantitative in vivo mapping of myocardial mitochondrial membrane potential. PLoS One. 2018; 13(1):e0190968.
    View in: PubMed
    Score: 0.014
  21. Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans. J Comp Neurol. 2016 May 01; 524(7):1457-71.
    View in: PubMed
    Score: 0.012
  22. Imaging PEG-like nanoprobes in tumor, transient ischemia, and inflammatory disease models. Bioconjug Chem. 2015 Jun 17; 26(6):1061-9.
    View in: PubMed
    Score: 0.012
  23. The effects of chronic alcohol self-administration on serotonin-1A receptor binding in nonhuman primates. Drug Alcohol Depend. 2014 Nov 01; 144:119-26.
    View in: PubMed
    Score: 0.011
  24. Changes in the a4ß2* nicotinic acetylcholine system during chronic controlled alcohol exposure in nonhuman primates. Drug Alcohol Depend. 2014 May 01; 138:216-9.
    View in: PubMed
    Score: 0.011
  25. Amyloid burden and neural function in people at risk for Alzheimer's Disease. Neurobiol Aging. 2014 Mar; 35(3):576-84.
    View in: PubMed
    Score: 0.011
  26. Specific a4ß2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey. Synapse. 2011 Dec; 65(12):1309-18.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.